Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 randomized double-blind study of eperisone BID vs TID vs placebo in acute low back pain
KCT0000925Phase 2Completed
- Sponsor
- Hanmi Pharmaceutical
- Start
- Feb 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of eperisone in acute lumbago, sponsored by Hanmi Pharmaceutical. Started Feb 2013; status: completed.
02
Drugs
eperisone
03
Conditions
acute lumbago
Beyond the preview
Go deeper on KCT0000925.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0000925.